EDITORIAL: Pharmacogenetics for Improving Efficacy and Safety in Drug Development and for Reducing Costs in Alzheimer’s Disease

Author(s): Ramón Cacabelos*

Alzheimer’s Disease (AD) is a growing health problem in terms of economics and care burden for families and health systems worldwide. The number of AD cases is estimated to rise from 57.4 million in 2019 to 152.8 million cases in 2050 (female-to-male ratio of 1.67-1.69), with considerable geographical differences in percentage increase (the highincome Asia Pacific, 53%; Western Europe, 74%; North Africa and the Middle East, 367%; Eastern sub-Saharan Africa, 357%) [1]. The average cost per patient/year ranges from $30,000 to $60,000, depending on the country (USA: $15,000/year; Europe: €7,000/year; Japan: JPY18 million/year), disease stage, quality of care and social status (global cost of dementia: US$800 billion worldwide; >1% GDP) [2].

Download for free: https://bit.ly/3FWwZAK

Podcast – Editorial: Image Perception

Journal Name: Current Medical Imaging
Formerly: Current Medical Imaging Reviews

Podcast by Author(s): Euishin Edmund Kim.

Volume 15 , Issue 9 , 2019

Web: https://www.eurekaselect.com/174515/a…

Subscribe to our YouTube channel for more: https://bit.ly/2Uq4Cm9

HIGHLIGHTED ARTICLE – EDITORIAL: MENTAL HEALTH IN EUROPE AND THE WORLD, WHAT AVENUES? – CURRENT PSYCHIATRY REVIEWS

To access the article, please visit: http://www.eurekaselect.com/157769/article

Author Testimonials

It has been an excellent experience working with Bentham Science, where the review process is fast and efficient, and the editorial staff is friendly and helpful. Bentham Science is a great place to publish your research paper, and I look forward to working with them further.

Prof. Xinyong Liu

Department of Medicinal Chemistry
School of Pharmaceutical Sciences
Shandong University, Shandong, P.R.China